PROFESSIONAL EDITION

The largest community of pharma leaders

Look Who’s On the Move!

Ikena Oncology Appoints Dr. Maria Koehler to its Board of Directors

BOSTON--(BUSINESS WIRE)--Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”), a targeted oncology company focused on developing cancer therapies targeting key signaling pathways that drive the formation...

Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics, Inc.

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating...

Tallac Therapeutics Appoints Curtis Hecht as Chief Business Officer

BURLINGAME, Calif.--(BUSINESS WIRE)--Tallac Therapeutics, Inc. (“Tallac”), a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, today announced...

CERo Therapeutics Expands Leadership Team with Experts in Cell Therapy Development

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CERo Therapeutics, Inc., a biopharmaceutical company pioneering the development of novel autologous engineered immune cellular therapies, today announced the expansion...

Recent Articles